These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33658356)

  • 1. Dual role of endothelial
    Kabir AU; Subramanian M; Lee DH; Wang X; Krchma K; Wu J; Naismith T; Halabi CM; Kim JY; Pulous FE; Petrich BG; Kim S; Park HC; Hanson PI; Pan H; Wickline SA; Fremont DH; Park C; Choi K
    Sci Transl Med; 2021 Mar; 13(583):. PubMed ID: 33658356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity.
    Lee WS; Yang H; Chon HJ; Kim C
    Exp Mol Med; 2020 Sep; 52(9):1475-1485. PubMed ID: 32913278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.
    Yang H; Lee WS; Kong SJ; Kim CG; Kim JH; Chang SK; Kim S; Kim G; Chon HJ; Kim C
    J Clin Invest; 2019 Jul; 129(10):4350-4364. PubMed ID: 31343989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenesis revisited: reshaping the treatment landscape of advanced non-small cell lung cancer.
    Choi SH; Yoo SS; Lee SY; Park JY
    Arch Pharm Res; 2022 Apr; 45(4):263-279. PubMed ID: 35449345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment.
    Kuo CL; Chou HY; Lien HW; Yeh CA; Wang JR; Chen CH; Fan CC; Hsu CP; Kao TY; Ko TM; Lee AY
    Cancer Immunol Immunother; 2023 Feb; 72(2):351-369. PubMed ID: 35895109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Vasculature as an Emerging Pharmacological Target to Promote Anti-Tumor Immunity.
    Tzeng HT; Huang YJ
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducing vascular normalization: A promising strategy for immunotherapy.
    Luo X; Zou W; Wei Z; Yu S; Zhao Y; Wu Y; Wang A; Lu Y
    Int Immunopharmacol; 2022 Nov; 112():109167. PubMed ID: 36037653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation.
    Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y
    J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis.
    Kabir AU; Lee TJ; Pan H; Berry JC; Krchma K; Wu J; Liu F; Kang HK; Hinman K; Yang L; Hamilton S; Zhou Q; Veis DJ; Mecham RP; Wickline SA; Miller MJ; Choi K
    JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
    Indraccolo S
    Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYCT1 in cancer development: Gene structure, regulation, and biological implications for diagnosis and treatment.
    Xu J; Sun Y; Fu W; Fu S
    Biomed Pharmacother; 2023 Sep; 165():115208. PubMed ID: 37499454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tie2-mediated vascular remodeling by ferritin-based protein C nanoparticles confers antitumor and anti-metastatic activities.
    Choi YS; Jang H; Gupta B; Jeong JH; Ge Y; Yong CS; Kim JO; Bae JS; Song IS; Kim IS; Lee YM
    J Hematol Oncol; 2020 Sep; 13(1):123. PubMed ID: 32928251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation.
    Collet G; Skrzypek K; Grillon C; Matejuk A; El Hafni-Rahbi B; Lamerant-Fayel N; Kieda C
    Vascul Pharmacol; 2012; 56(5-6):252-61. PubMed ID: 22446152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of the tumor microvasculature based on targeting and modulation of the tumor microenvironment.
    Li Z; Ning F; Wang C; Yu H; Ma Q; Sun Y
    Nanoscale; 2021 Oct; 13(41):17254-17271. PubMed ID: 34651623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications.
    Tamura R; Tanaka T; Akasaki Y; Murayama Y; Yoshida K; Sasaki H
    Med Oncol; 2019 Nov; 37(1):2. PubMed ID: 31713115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates.
    Wei F; Su Y; Quan Y; Li X; Zou Q; Zhang L; Li S; Jiang M; Lin G; Liang P; He J; Xie K
    Clin Cancer Res; 2023 Jul; 29(13):2525-2539. PubMed ID: 36729148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of vascular adhesion protein-1 enhances the anti-tumor effects of immune checkpoint inhibitors.
    Kinoshita T; Sayem MA; Yaguchi T; Kharma B; Morii K; Kato D; Ohta S; Mashima Y; Asamura H; Kawakami Y
    Cancer Sci; 2021 Apr; 112(4):1390-1401. PubMed ID: 33453147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Immunotherapy with "Vascular-Immune" Crosstalk as Entry Point: Associated Mechanisms, Therapeutic Drugs and Nano-Delivery Systems.
    Jiang Z; Fang Z; Hong D; Wang X
    Int J Nanomedicine; 2024; 19():7383-7398. PubMed ID: 39050878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.